About Abcam
Abcam is a company based in Cambridge (United Kingdom) founded in 1998 by Avner Dahan and Tony Kouzarides was acquired by Danaher in August 2023.. Abcam has raised $78.8 million across 6 funding rounds from investors including Danaher, HHS and National Science Foundation. Abcam has completed 12 acquisitions, including Ascent Scientific, AxioMx and BioVision. Abcam offers products and services including Primary Antibodies, ELISA Kits, and Cell Lines. Abcam operates in a competitive market with competitors including Stem Cell Technologies, Meridian Bioscience, Teknova, Sangon Biotech and Cayman Chem, among others.
- Headquarter Cambridge, United Kingdom
- Founders Avner Dahan, Tony Kouzarides
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Abcam Limited
- Date of Incorporation 12 Feb, 1998
- Jurisdiction CAMBRIDGE, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$78.8 M (USD)
in 6 rounds
-
Latest Funding Round
$258.66 M (USD), Debt – Conventional
May 15, 2019
-
Investors
Danaher
& 2 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Ascent Scientific
& 11 more
-
Acquired by
Danaher
(Aug 26, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Abcam
Abcam offers a comprehensive portfolio of products and services, including Primary Antibodies, ELISA Kits, and Cell Lines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Antibodies for detecting specific proteins in biological samples
Kits for measuring proteins and analytes in research assays
Gene-edited cells for experimental and therapeutic studies
Unlock access to complete
Unlock access to complete
Sales and Marketing
18 people
Software Development Team
17 people
Senior Team
15 people
Product Management Team
9 people
Leadership Team
5 people
Finance and Accounting
5 people
Human Resources and Administration
5 people
Head Team
4 people
Unlock access to complete
Funding Insights of Abcam
Abcam has successfully raised a total of $78.8M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $258.66 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Debt – Conventional — $258.7M
-
First Round
First Round
(03 Aug 2009)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2019 | Amount | Debt – Conventional - Abcam | Valuation |
investors |
|
| Jul, 2013 | Amount | Grant - Abcam | Valuation |
investors |
|
| Apr, 2012 | Amount | Private Equity Round - Abcam | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Abcam
Abcam has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Danaher, HHS and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location | |
|
Dental equipment and medical instruments are manufactured for therapeutic areas.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Abcam
Abcam has strategically engaged in corporate development activities, having acquired 12 companies. Notable acquisitions include Ascent Scientific, AxioMx and BioVision. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Age-related disorders are addressed through senescent biology research.
|
2013 | ||||
|
A recombinant antibody discovery and development platform is operated.
|
2012 | ||||
|
Custom rabbit monoclonal antibodies are developed for research applications.
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Abcam
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Abcam Comparisons
Competitors of Abcam
Abcam operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stem Cell Technologies, Meridian Bioscience, Teknova, Sangon Biotech and Cayman Chem, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic device and kits
|
|
| domain | founded_year | HQ Location |
Molecular biology reagents and kits are supplied for research applications.
|
|
| domain | founded_year | HQ Location |
Research services, reagents, and kits for biotech applications are provided.
|
|
| domain | founded_year | HQ Location |
Bioreagents and assay kits are developed, with preclinical services provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Abcam
Frequently Asked Questions about Abcam
When was Abcam founded?
Abcam was founded in 1998 and raised its 1st funding round 11 years after it was founded.
Where is Abcam located?
Abcam is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Is Abcam a funded company?
Abcam is a funded company, having raised a total of $78.8M across 6 funding rounds to date. The company's 1st funding round was a Private Equity Round of $77M, raised on Aug 03, 2009.
What does Abcam do?
Abcam was founded in 1998 in Cambridge, United Kingdom, within the life sciences sector. Biological reagents are produced for research applications, encompassing primary and secondary antibodies, immunoassay kits, cellular imaging tools, biochemical assays, proteins, peptides, proteomic tools, agonists, antagonists, activators, inhibitors, lysates, and miRNA assays. Operations focus on supporting scientific investigations through these specialized products.
Who are the top competitors of Abcam?
Abcam's top competitors include Meridian Bioscience, Stem Cell Technologies and BBI Solutions.
What products or services does Abcam offer?
Abcam offers Primary Antibodies, ELISA Kits, and Cell Lines.
How many acquisitions has Abcam made?
Abcam has made 12 acquisitions, including Ascent Scientific, AxioMx, and BioVision.
Who are Abcam's investors?
Abcam has 3 investors. Key investors include Danaher, HHS, and National Science Foundation.